HBOT vs Ozone Therapy vs IV NAD+: When Each One Makes Sense
Explore the clinic directoryIn this article
- How do HBOT, ozone, and IV NAD+ differ?
- Head-to-head comparison
- Ozone therapy vs hyperbaric oxygen: which has better evidence by condition?
- Hyperbaric chamber vs ozone therapy: what happens in a session?
- What are the types of ozone therapy?
- When should you choose each therapy?
- Can you stack these therapies?
- NAD+ and ozone for anti-aging: what does the evidence say?
- What are the risks and contraindications of each?
- Who provides HBOT, ozone therapy and IV NAD+?
- Frequently asked questions
- Sources
Ozone therapy and hyperbaric oxygen therapy (HBOT) are different treatments: HBOT has you breathe 100% oxygen in a pressurized chamber so extra oxygen dissolves into your blood plasma, while ozone therapy puts ozone (O3) into blood, joints or tissue to trigger an antioxidant and immune response. HBOT has 14 FDA-cleared indications and ozone therapy has none, and in the only head-to-head human trial HBOT reduced venous leg ulcer area by 69.7% versus 41.3% for ozone (Pasek et al., 2023).1
What this article covers
HBOT, ozone therapy, and IV NAD+ are three different treatments that share an “oxygen and cellular energy” reputation but work through unrelated mechanisms. IV NAD+, the third option people often weigh against the other two, also has zero FDA-approved indications. The sections below set out how each one works, what the evidence shows, what a session involves, and when each makes sense.
Key takeaways
- Hyperbaric oxygen therapy raises arterial oxygen tension to roughly 1,500 mmHg at 2.0 to 2.4 ATA, about 15 times the sea-level value (Thom, 2011).
- HBOT has 14 FDA-cleared indications, such as diabetic wounds, radiation injury, decompression sickness and carbon monoxide poisoning, while ozone therapy and IV NAD+ have none (UHMS, FDA).
- In the only head-to-head human trial, topical HBOT shrank venous leg ulcers by 69.7% versus 41.3% for local ozone, while ozone gave better pain relief (Pasek et al., 2023).
- A 2018 systematic review of 9 RCTs (n=453) found ozone improved chronic wound closure but gave no conclusive evidence of superiority over standard care (Fitzpatrick et al., 2018).
- A 2024 placebo-controlled pilot RCT found IV nicotinamide riboside raised blood NAD+ more than IV NAD+ at 3 hours, with fewer side effects (Hawkins et al., 2024).
- No published trial has tested HBOT, ozone and IV NAD+ in combination, so stacking them rests on mechanism and clinical observation.
How do HBOT, ozone, and IV NAD+ differ?
All three raise oxygen or cellular-energy activity, but by different routes. HBOT dissolves extra oxygen into blood plasma under pressure. Ozone therapy introduces a reactive oxygen molecule that triggers an antioxidant response. IV NAD+ replenishes a coenzyme used in energy metabolism. They treat different conditions best and are not interchangeable.
Put simply, HBOT changes how much oxygen reaches your tissues, ozone therapy changes how your cells respond to oxidative signals, and IV NAD+ changes the supply of a molecule your mitochondria use for energy.
- Pressurized O2 dissolves into plasma
- 14 FDA-cleared indications
- 69.7% venous ulcer area reduction (head-to-head)
- $150 to $400 per session
- Reactive O3 triggers antioxidant response
- Not FDA-approved in the US
- 41.3% venous ulcer area reduction (head-to-head)
- Widely practiced in Europe
Hyperbaric oxygen therapy (HBOT)
HBOT places you in a pressurized chamber breathing 100% oxygen (in a hard chamber) or concentrated air (in a soft chamber). The elevated pressure dissolves oxygen directly into blood plasma at levels breathing alone cannot reach. At 2.0 to 2.4 ATA (atmospheres absolute) with 100% oxygen, arterial oxygen tension rises to roughly 1,500 mmHg, about 15 times the sea-level value, and plasma-dissolved oxygen increases roughly 10 to 15 fold (Thom, 2011).4
This hyperoxygenation drives several downstream effects: angiogenesis (new blood vessel formation), stem cell mobilization from bone marrow, reduced inflammation through suppression of pro-inflammatory cytokines, enhanced white blood cell bacterial killing, and activation of hypoxia-inducible factor (HIF-1) pathways that regulate tissue-repair genes (Thom, 2011).4
FDA status: HBOT is cleared for 14 specific medical indications and used off-label for many others. In the only head-to-head human trial against ozone therapy (Pasek et al., 2023), topical HBOT reduced venous ulcer area by 69.7% versus 41.3% for local ozone, while ozone produced greater pain relief.1
The hyperbaric oxygen therapy treatment guide covers the full indication list, chamber types and session protocols. Soft chambers that run at lower pressure on room air or concentrated air are a different product from the 2.0 to 2.4 ATA clinical protocols described above; the mild HBOT versus clinical HBOT comparison explains where that line falls.
Ozone therapy
Ozone therapy introduces ozone (O3), a reactive form of oxygen, into the body through several routes: major autohemotherapy (withdrawing blood, mixing it with ozone, and reinfusing it), rectal or vaginal insufflation, or injection into joints or tissues.
The mechanism differs fundamentally from HBOT. Ozone does not raise tissue oxygenation through pressure. Instead it creates a controlled oxidative stress that upregulates the body’s antioxidant defenses (superoxide dismutase, catalase, glutathione peroxidase), modulates the immune system, and has antimicrobial effects. A 2018 systematic review of 9 RCTs (n=453) found ozone significantly improved chronic wound closure, though the authors reported “no conclusive evidence” of superiority over standard care (Fitzpatrick et al., 2018).2 Animal studies comparing the two therapies directly, in models of colitis and acute pancreatitis, found both reduced tissue injury with broadly similar effect (Altinel et al., 2011; Uysal et al., 2010).56
FDA status: The FDA has not approved ozone as a medical treatment in the United States, and under 21 CFR 801.415 ozone is described as having no known useful medical application in concentrations high enough to be effective as a germicide.7 Ozone therapy is practiced in the US under physician discretion and is more widely used in Europe and Latin America.
Medical ozone is an oxygen and ozone blend made on site by a generator, and protocols vary widely between practitioners. The ozone therapy treatment guide describes each route and its typical uses in more detail.
IV NAD+ therapy
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every cell. It is central to mitochondrial energy production, DNA repair, and sirtuin activation (linked to longevity pathways). NAD+ levels decline with age, chronic illness, and metabolic stress.
IV NAD+ therapy delivers the coenzyme directly into the bloodstream, bypassing digestion for higher bioavailability than oral supplements. Typical infusions run 250 to 1,000 mg over 2 to 6 hours. Proposed mechanisms include restoring mitochondrial function, supporting DNA repair, and reducing neuroinflammation.
FDA status: NAD+ is not FDA-approved for any specific condition. It is given as a nutritional supplement or compounded preparation under physician supervision. A 2024 placebo-controlled pilot RCT found that IV nicotinamide riboside (NR) raised blood NAD+ levels more than IV NAD+ at 3 hours, with shorter infusion times and fewer side effects (Hawkins et al., 2024).3
Oral precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are the cheaper alternative most people compare against the drip; the IV NAD+ versus oral supplements breakdown covers that choice, and the NAD+ IV therapy guide covers dosing and what an infusion involves.
Head-to-head comparison
| Factor | HBOT | Ozone Therapy | IV NAD+ |
|---|---|---|---|
| Mechanism | Pressure-driven plasma hyperoxygenation (roughly 10 to 15x dissolved O2) | Controlled oxidative stress upregulates antioxidant pathways; modulates cytokines | Coenzyme replenishment supporting sirtuin activation, DNA repair, mitochondrial ATP |
| Evidence level | Strong. 14 FDA-cleared indications, multiple Cochrane reviews | Emerging. Systematic reviews exist but are small and at high risk of bias; no FDA approval | Limited. Mostly small pilots; a 2024 RCT questions IV NAD+ versus IV NR |
| Typical protocol | 60 to 90 min sessions, 20 to 60 sessions, 5x/week at 2.0 to 2.4 ATA | 30 to 60 min sessions, 10 to 20 sessions; no standardized dosing | 2 to 4 hour IV drip; 5 to 10 sessions; 250 to 500 mg per infusion |
| Cost range | $150 to $400/session; full course $5,000 to $15,000; Medicare covers approved uses | $100 to $300/session; 10 to 20 sessions: $2,000 to $5,000; rarely insured | $500 to $1,000/session; 5 to 10 sessions: $5,000 to $10,000+; never insured |
| FDA status | Cleared for 14 conditions | Not FDA-approved; restricted in some US states | Not FDA-approved as therapy; sold as a wellness service or compounded preparation |
| Side effects | Ear barotrauma (common, mild); O2 toxicity seizures (rare); claustrophobia; temporary myopia | Air embolism risk (IV route); oxidative damage if overdosed; respiratory irritation | Nausea, chest pressure, GI symptoms, raised heart rate during infusion |
| Best-supported conditions | Diabetic wounds, radiation injury, decompression sickness, CO poisoning, sudden hearing loss | Chronic wounds (weak evidence); dental infections (emerging); joint pain (emerging) | Fatigue and addiction withdrawal (very small studies) |
| Best first choice for | A condition with published HBOT evidence or an FDA-cleared indication | Chronic infection or immune modulation, as an adjunct | Suspected mitochondrial fatigue, as a short adjunct |
Insurance follows the evidence. Medicare and most private insurers pay for HBOT only for the covered indications in Medicare’s national coverage determination for hyperbaric oxygen therapy (NCD 20.29), while ozone therapy and IV NAD+ are paid out of pocket. Off-label HBOT for long COVID, TBI or wellness goals is usually cash pay as well; the hyperbaric chamber cost breakdown and the ozone therapy cost guide show how pricing is structured.
Ozone therapy vs hyperbaric oxygen: which has better evidence by condition?
HBOT has the stronger evidence for wounds and for every condition on the FDA-cleared list. Ozone therapy has more of its own data for joint and spine pain and for dental use, though most trials are small. IV NAD+ has no condition-level trial evidence of benefit yet. The table below sums up where each stands for the conditions people most often ask about.
| Condition | HBOT | Ozone therapy | IV NAD+ |
|---|---|---|---|
| Diabetic foot ulcers | A UHMS-listed indication; a Cochrane review (Kranke et al., 2015) found improved short-term healing. | Small trials; the Fitzpatrick et al. (2018) review found no conclusive edge over standard care. | No trials. |
| Venous leg ulcers | Topical HBOT gave more wound-area reduction in the only head-to-head trial (Pasek et al., 2023). | Gave better pain relief in the same trial. | No trials. |
| Knee and joint pain, osteoarthritis | Not an indication; little trial data. | Intra-articular ozone injections have small RCTs reporting short-term pain relief. | No trials. |
| Herniated disc and low back pain | Not an indication. | Intradiscal and paravertebral ozone is used in Europe, with mixed trial quality. | No trials. |
| Long COVID | Off-label; a small sham-controlled RCT reported cognitive gains (Zilberman-Itskovich et al., 2022). | Off-label; no controlled trials. | Off-label; very small studies only. |
| Traumatic brain injury and post-concussion syndrome | Off-label; trials are mixed and debated. | No trials. | No trials. |
| Lyme disease and chronic infection | Off-label; uncontrolled reports only. | Off-label and widely offered; no controlled trials. | Off-label; no trials. |
| Carbon monoxide poisoning, decompression sickness | Standard hospital treatment and FDA-cleared indications. | No role. | No role. |
For readers starting from a diagnosis, the condition pages on long COVID, traumatic brain injury, osteoarthritis and Lyme disease list the treatments clinics offer for each and how strong the evidence is. The FDA-cleared HBOT indications post lists the covered conditions one by one.
Hyperbaric chamber vs ozone therapy: what happens in a session?
HBOT is a long, quiet session under pressure; ozone therapy is usually a shorter procedure built around a blood draw, an injection or an insufflation.
What to expect in a hyperbaric chamber
You lie or sit in a monoplace chamber (one person, usually a clear acrylic tube) or a multiplace chamber (a room for several people breathing oxygen through hoods or masks). Pressure rises over several minutes, and you clear your ears as you would on a descending flight. A clinical session runs 60 to 90 minutes at 2.0 to 2.4 ATA, and courses run 20 to 60 sessions, often five days a week. You can usually drive home afterward.
What to expect in an ozone therapy session
For major autohemotherapy, a clinician draws blood into a sterile bag or bottle, mixes it with a measured oxygen and ozone gas blend, and drips it back through the same IV line. Most sessions take 30 to 60 minutes, with a course of 10 to 20 sessions and no standardized dosing. Joint injections take minutes, and rectal insufflation is brief.
What to expect during an IV NAD+ infusion
IV NAD+ is the slowest of the three. An infusion of 250 to 500 mg usually takes 2 to 4 hours because running it faster tends to cause nausea, chest pressure and cramping.
What are the types of ozone therapy?
Ozone therapy is a family of procedures, not one treatment, and the route decides the dose, the risk and what the evidence says.
- Major autohemotherapy (MAH): blood is drawn, mixed with ozone outside the body and reinfused. This is what most clinics mean by an “ozone IV” or ozone infusion; the ozone infusion therapy overview walks through it.
- Multi-pass autohemotherapy: the MAH cycle repeated several times in one sitting, marketed as 10-pass ozone therapy.
- EBOO (extracorporeal blood oxygenation and ozonation): blood circulates through a filter outside the body while it is exposed to ozone, similar in setup to dialysis. The EBOO versus 10-pass comparison explains the difference.
- Rectal and vaginal insufflation: ozone gas introduced into the rectum or vagina, the route most often used at home.
- Injections into joints, discs and soft tissue: sometimes called prolozone, used for knee pain and herniated discs.
- Topical and dental ozone: ozonated oils, gas “bagging” of a limb, and ozonated water or gas in dentistry.
Direct intravenous injection of ozone gas is a different and riskier practice than MAH, because gas entering a vein can cause an embolism. Ozone is never meant to be inhaled; it irritates the lungs at low concentrations, and the FDA sets a maximum acceptable ozone level for medical devices under 21 CFR 801.415.7
When should you choose each therapy?
Choose by the condition and the evidence for it, not by which therapy sounds most like “more oxygen.” HBOT comes first when your condition is on the cleared list or has trial data; ozone and IV NAD+ are adjuncts with thinner evidence.
Choose HBOT when:
- You have a condition with published HBOT evidence (long COVID, TBI, stroke recovery, diabetic wounds, radiation injury)
- You need tissue-level repair, not just systemic modulation
- Your condition involves poor blood flow or oxygen delivery to specific tissues
- You want the therapy with the strongest regulatory and evidence base (see the HBOT alternatives comparison)
Choose ozone therapy when:
- You are dealing with chronic infection where immune modulation is the priority
- You want to support antioxidant capacity as an adjunct
- You have joint conditions where direct ozone injection may help
- You are already doing HBOT and want a therapy that works through a different mechanism. Review 10-pass ozone therapy cost before committing to a course
Choose IV NAD+ when:
- Fatigue, brain fog, or low energy are your primary complaints and you suspect mitochondrial dysfunction
- You are in addiction recovery, where NAD+ has been used in detox protocols
- You want a shorter-term intervention that can complement a longer HBOT course
Can you stack these therapies?
Yes, and many integrative practitioners do, though no published trial has tested the combinations directly. Because the three target different systems, the rationale is mechanistic rather than trial-based:
- HBOT plus IV NAD+: used for TBI and long COVID. HBOT drives tissue repair; NAD+ supports the mitochondrial energy those repair processes require.
- HBOT plus ozone therapy: used in chronic-infection protocols. HBOT raises tissue oxygen; ozone modulates the immune response.
- All three: some longevity clinics offer the full stack, targeting tissue oxygenation (HBOT), immune function (ozone), and cellular energy (NAD+).
No published study has examined these combinations head-to-head. The stacking approach rests on mechanistic reasoning and clinical observation, not randomized trial data.
Stacking also multiplies cost, so a sensible order is to start with the therapy that has evidence for your condition, track one clear measure, and add a second only if the first leaves a gap.
NAD+ and ozone for anti-aging: what does the evidence say?
No human trial shows that IV NAD+ or ozone therapy slows aging. IV NAD+ and oral precursors such as NR and NMN raise blood NAD+ levels, which is a measurable change in a biomarker, but trials have not shown that this translates into longer life or fewer age-related diseases. Ozone therapy’s anti-aging case rests on its antioxidant-signaling mechanism and has no controlled human outcome data.
HBOT has slightly more to point to. A small single-arm study of healthy older adults found longer telomeres and fewer senescent immune cells after a three-month course of HBOT (Hachmo et al., 2020), but it had no control group and measured blood markers, not health outcomes. The NAD+ and anti-aging review and the HBOT for longevity post go through these studies in detail.
What are the risks and contraindications of each?
Each therapy has its own risks and its own reasons to say no.
- HBOT: ear and sinus barotrauma is the most common problem; oxygen toxicity seizures are rare; temporary nearsightedness can develop over a long course. An untreated pneumothorax (collapsed lung) is an absolute contraindication, and some chemotherapy drugs, uncontrolled seizures and severe claustrophobia need a physician’s review first. The hyperbaric chamber side effects guide covers each.
- Ozone therapy: risks depend on the route and include gas embolism with direct IV injection, vein irritation, and lung irritation if ozone is inhaled. G6PD deficiency, pregnancy and uncontrolled hyperthyroidism are commonly listed contraindications. The IV ozone therapy side effects post lists what clinics screen for.
- IV NAD+: nausea, flushing, chest tightness, cramping and a raised heart rate are common during fast infusions and usually settle when the drip slows. Safety data in pregnancy are lacking.
Who provides HBOT, ozone therapy and IV NAD+?
Different clinicians run each therapy. Hospital wound centers and hyperbaric units are led by physicians with board certification in Undersea and Hyperbaric Medicine, offered through the American Board of Preventive Medicine and the American Board of Emergency Medicine, and chambers are operated by certified hyperbaric technologists (CHT) credentialed by the National Board of Diving and Hyperbaric Medical Technology.
Ozone therapy is mostly offered by integrative and functional medicine physicians (MDs and DOs), naturopathic doctors in states where their scope allows it, pain specialists for joint and disc injections, and dentists for dental ozone. IV NAD+ is given at IV therapy clinics and longevity practices, usually by nurses working under a physician’s orders.
The directory lets you compare all three: browse hyperbaric oxygen therapy clinics, clinics offering ozone therapy and NAD+ IV therapy providers by state and city. Listing order is not paid ranking, Featured slots are labeled and capped, Verified means credential checks rather than spend, and Regenerated.com is free for patients; the guide to Featured, Verified and organic listings explains each label. Inclusion in the directory is not an endorsement, so ask any clinic who supervises treatment, what pressure or dose they use, and what outcome they will track.
Frequently asked questions
Is HBOT better than ozone therapy?
For wound healing and every FDA-cleared condition, HBOT has the stronger evidence: it is cleared for 14 indications and ozone therapy for none. The one head-to-head human trial (Pasek et al., 2023) found HBOT superior for venous ulcer closure (69.7% versus 41.3% area reduction), while ozone gave better pain relief.1 They work through different mechanisms, and ozone has a longer history in European medicine for immune modulation and joint pain.
Is IV NAD+ worth the cost?
For most people, IV NAD+ is expensive relative to its evidence: infusions run $500 to $1,000 each and insurance does not pay. A 2024 placebo-controlled pilot RCT found IV nicotinamide riboside raised blood NAD+ levels more than IV NAD+ with fewer side effects (Hawkins et al., 2024).3 If fatigue and brain fog are your main issues, discuss IV NR with your provider too. For conditions with stronger HBOT evidence, start with HBOT and consider NAD+ as an adjunct.
Can I do ozone therapy at home?
Some patients do rectal ozone insufflation at home with purchased equipment, but home ozone is less regulated than clinic-based autohemotherapy and carries added safety risk. Ozone is a respiratory irritant and must not be inhaled, so leaks from a home generator matter. If you pursue it, work with a practitioner who can supervise your protocol and confirm you are using medical-grade equipment, and keep any IV route in a clinic.
Which therapy should I try first?
Start with the therapy that has the strongest evidence for your specific condition. For most conditions Regenerated.com covers (long COVID, TBI, stroke, wound healing), that is HBOT. If your primary issue is chronic infection or immune dysfunction, ask an integrative practitioner about ozone. If fatigue and mitochondrial function are your main concern, IV NAD+ or IV NR may be a reasonable starting point, with a clear measure agreed in advance.
Is ozone therapy the same as hyperbaric oxygen therapy?
No. Hyperbaric oxygen therapy has you breathe 100% oxygen (O2) in a chamber pressurized to 2.0 to 2.4 ATA, which dissolves extra oxygen into plasma. Ozone therapy uses ozone (O3), a less stable three-atom form of oxygen, mixed with blood or injected into tissue to set off a controlled oxidative signal. Both get called oxygen therapies, but the mechanism, regulation and evidence differ, and one does not substitute for the other.
What is an ozone infusion?
An ozone infusion usually means major autohemotherapy: a clinician draws blood, mixes it with a measured oxygen and ozone gas blend outside the body, and drips it back into a vein. Multi-pass versions such as 10-pass ozone and EBOO repeat or extend that cycle in one sitting. None is FDA approved. Direct injection of ozone gas into a vein is a separate, riskier practice linked to gas embolism.
Sources
- Pasek J, Szajkowski S, Cieslar G. Topical hyperbaric oxygen therapy versus local ozone therapy in healing of venous leg ulcers. Int J Environ Res Public Health. 2023;20(3):1967. DOI: 10.3390/ijerph20031967
- Fitzpatrick E, Holland O, Vanderlelie J. Ozone therapy for the treatment of chronic wounds: a systematic review. Int Wound J. 2018;15(4):633-644. DOI: 10.1111/iwj.12907
- Hawkins J et al. Randomized, placebo-controlled pilot clinical study evaluating acute intravenous NR and NAD+ in healthy adults. medRxiv. 2024. DOI: 10.1101/2024.06.06.24308565
- Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg. 2011;127(Suppl 1):131S-141S. DOI: 10.1097/PRS.0b013e3181fbe2bf
- Altinel O et al. Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scand J Clin Lab Invest. 2011;71(3):185-192. DOI: 10.3109/00365513.2010.548875
- Uysal B et al. Efficacy of hyperbaric oxygen therapy and medical ozone therapy in experimental acute necrotizing pancreatitis. Pancreas. 2010;39(1):9-15. DOI: 10.1097/MPA.0b013e3181bb5ae3
- U.S. Food and Drug Administration. Maximum acceptable level of ozone, 21 CFR 801.415. accessdata.fda.gov
- Undersea and Hyperbaric Medical Society. Approved indications for hyperbaric oxygen therapy. uhms.org